Bridging chimeric antigen receptor T-cell before transplantation improves prognosis of relapsed/refractory B-cell acute lymphoblastic leukemia

被引：0
|
作者：
Zhao, Xiangyu [1 ]
Wu, Haotian [2 ]
Cheng, Yifei [1 ]
Xu, Zhengli [1 ]
Chen, Yuhong [1 ]
Chang, Yingjun [1 ]
Wang, Yu [1 ]
Zhang, Xiaohui [1 ]
Xu, Lanping [1 ]
Huang, Xiaojun [1 ,3 ]
机构：
[1] Natl Clin Res Ctr Hematol Dis, Peking Univ Peoples Hosp, Peking Univ Inst Hematol, Dept Hematol,Beijing Key Lab Hematopoiet Stem Cel, Beijing 100044, Peoples R China
[2] Peking Univ, Hlth Sci Ctr, Beijing 100191, Peoples R China
[3] Peking Tsinghua Ctr Life Sci, Beijing 100871, Peoples R China
来源：
CHINESE MEDICAL JOURNAL | 2023年 / 136卷 / 16期
基金：
中国国家自然科学基金;
关键词：
D O I：
10.1097/CM9.0000000000002764
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
[No abstract available]
引用
收藏
页码：2011 / 2013
页数：3
相关论文
共 50 条
  • [1] Bridging chimeric antigen receptor T-cell before transplantation improves prognosis of relapsed/refractory B-cell acute lymphoblastic leukemia
    Zhao Xiangyu
    Wu Haotian
    Cheng Yifei
    Xu Zhengli
    Chen Yuhong
    Chang Yingjun
    Wang Yu
    Zhang Xiaohui
    Xu Lanping
    Huang Xiaojun
    [J]. 中华医学杂志英文版., 2023, 136 (16)
  • [2] Cost Effectiveness of Chimeric Antigen Receptor T-Cell Therapy in Relapsed or Refractory Pediatric B-Cell Acute Lymphoblastic Leukemia
    Lin, John K.
    Lerman, Benjamin J.
    Barnes, James I.
    Boursiquot, Brian C.
    Tan, Yuan Jin
    Robinson, Alex Q. L.
    Davis, Kara L.
    Owens, Douglas K.
    Goldhaber-Fiebert, Jeremy D.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (32) : 3192 - +
  • [3] Cost-Effectiveness of Chimeric Antigen Receptor T-Cell Therapy in Pediatric Relapsed/Refractory B-Cell Acute Lymphoblastic Leukemia
    Sarkar, Reith R.
    Gloude, Nicholas J.
    Schiff, Deborah
    Murphy, James D.
    [J]. JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2019, 111 (07) : 719 - 726
  • [4] Chimeric antigen receptor T-cell therapy in adults with B-cell acute lymphoblastic leukemia
    Grover, Punita
    Veilleux, Olivier
    Tian, Lu
    Sun, Ryan
    Previtera, Melissa
    Curran, Emily
    Muffly, Lori
    [J]. BLOOD ADVANCES, 2022, 6 (05) : 1608 - 1618
  • [5] Allogeneic chimeric antigen receptor T cells for children with relapsed/refractory B-cell precursor acute lymphoblastic leukemia
    Locatelli, Franco
    del Bufalo, Francesca
    Quintarelli, Concetta
    [J]. HAEMATOLOGICA, 2024, 109 (06) : 1689 - 1699
  • [6] CD19 chimeric antigen receptor-T cells as bridging therapy to allogeneic hematopoietic cell transplantation improves outcome in patients with refractory/relapsed B-cell acute lymphoblastic leukemia
    Liu, Jie
    Xu, Mengyuan
    Zhang, Xiaoqian
    Zhang, Zhuo
    Zhong, Tao
    Yu, Hongjuan
    Fu, Yueyue
    Meng, Hongbin
    Feng, Jiawei
    Zou, Xindi
    Han, Xueying
    Kang, Liqing
    Yu, Lei
    Li, Limin
    [J]. HELIYON, 2024, 10 (13)
  • [7] Bridging Radiation Therapy Before Commercial Chimeric Antigen Receptor T-Cell Therapy for Relapsed or Refractory Aggressive B-Cell Lymphoma
    Wright, Christopher M.
    LaRiviere, Michael J.
    Baron, Jonathan A.
    Uche, Chibueze
    Xiao, Ying
    Arscott, W. Tristram
    Anstadt, Emily J.
    Barsky, Andrew R.
    Miller, David
    LaRose, Meredith, I
    Landsburg, Daniel J.
    Svoboda, Jakub
    Nasta, Sunita D.
    Gerson, James N.
    Barta, Stefan K.
    Chong, Elise A.
    Schuster, Stephen J.
    Paydar, Ima
    Maity, Amit
    Plastaras, John P.
    [J]. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2020, 108 (01): : 178 - 188
  • [8] Exudative Retinal Detachment Following Chimeric Antigen Receptor T-Cell Therapy in Relapsed B-Cell Acute Lymphoblastic Leukemia
    Khanna, Saira
    Mackin, Anna G.
    Dao, David T.
    Komati, Rahul
    Morocco, Perry C.
    LaBelle, James L.
    Shah, Hassan A.
    Blair, Michael P.
    [J]. OPHTHALMIC SURGERY LASERS & IMAGING RETINA, 2022, 53 (02): : 113 - 115
  • [9] Consolidative allogeneic hematopoietic stem cell transplantation after chimeric antigen receptor T-cell therapy for relapsed/refractory B-cell acute lymphoblastic leukemia: who? When? Why?
    Jiang, Huiwen
    Hu, Yu
    Mei, Heng
    [J]. BIOMARKER RESEARCH, 2020, 8 (01)
  • [10] Consolidative allogeneic hematopoietic stem cell transplantation after chimeric antigen receptor T-cell therapy for relapsed/refractory B-cell acute lymphoblastic leukemia: who? When? Why?
    Huiwen Jiang
    Yu Hu
    Heng Mei
    [J]. Biomarker Research, 8
12345